Early Safety of Resection Recopy and Sacrocolpopexy (RRPSCPcomb)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05910021 |
Recruitment Status :
Recruiting
First Posted : June 18, 2023
Last Update Posted : June 23, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Constipation by Outlet Obstruction Pelvic Organ Prolapse Urinary Incontinence |
Obstructive defecation syndrome (ODS) defines a disturbed defecation process caused by the protrusion of the lower rectum (rectocele) or the telescoping within the rectum (intussusception). The patients must exert pressure to evacuate the rectum and manual manipulation may be required. The unsuccessful attempts to defecate are associated with a feeling of incomplete rectal voiding. ODS affects approximately 10%-25% of the population and is mainly related to female sex. The condition is frequently associated with POP. On the other hand almost 60% of the female population develop POP during their lifetime and 1/3 of them suffer bowel dysfunction. Individual aspects, such as pregnancy, childbirth, connective tissue disorders, and surgical interventions further contribute to the condition. The women experience frustration due to their disturbed defecation, compromising their quality of life substantially. Conservative treatment options are limited and do not achieve the desired long-term effect.
The surgical treatment aims at the anatomic reconstruction of the bowel and pelvic floor and has been characterized by individual approaches.
This pilot study established and standardized an interdisciplinary surgical approach of laparoscopic resection rectopexy (L-RRP) combined with a laparoscopic mesh sacrocolpopexy (L-SCP) used synonymously for all surgical reconstructions. Additionally, an absorbable biological mesh (BM) for L-SCP was offered for women who wished to preserve the uterus in cases of a planned pregnancy and those, who asked for an alternative to the synthetic mesh (SM).
- Endpoints of the study The primary study outcome parameters were the safety and efficacy of the combined laparoscopic procedure.as measured by postoperative morbidity and mortality and measured. The secondary outcome parameters were clinical and anatomical outcomes as measured by scores.
- Data management and statistical analysis The necessary clinical data were collected preoperatively, during the hospital stay, and during the follow-up examinations. All scores were documented on paper and transferred to a data bank. Data were analyzed. Quantitative variables are described as means (± standard deviation) and were compared using the Kruskal-Wallis H test and Mann-Whitney U test. Qualitative variables are summarized using count, percentage, median, and interquartile range and were compared using the Fisher's exact test. A two-sided p value of <0.05 was considered statistically significant. Because no adjustments for multiple testing were performed, the analysis were exploratory.
Study Type : | Observational |
Estimated Enrollment : | 100 participants |
Observational Model: | Other |
Time Perspective: | Retrospective |
Official Title: | Early Safety and Efficiency of Interdisciplinary Laparoscopic Resection Rectopexy Combined With Sacrocolpopexy for Women With Obstructive Defecation Syndrome and Pelvic Organ Prolapse |
Actual Study Start Date : | February 1, 2020 |
Estimated Primary Completion Date : | December 31, 2024 |
Estimated Study Completion Date : | November 30, 2025 |
Group/Cohort |
---|
Women with ODS and POP
This pilot study established and standardized an interdisciplinary surgical approach of laparoscopic resection rectopexy (L-RRP) combined with a laparoscopic mesh sacrocolpopexy (L-SCP) used synonymously for sacrohysteropey and sacrocervicopexy, as well. Additionally, an absorbable biological mesh (
|
- Safety of the procedure [ Time Frame: 12 months ]Complication after Surgery by Clavien Dingo Score (minimum 0=no complication, 1= complication with no intervention, 2= complication with need for medication, 3a= complication with need for intervention, 3b = need for intervention under general anesthesia, 4a = septic complication, 4b= Multiorgan failure, and maximum 5= death
- pelvic organ prolapse (POP) [ Time Frame: 12 months ]POP measured by POP-Q (Score ranges from 0= no POP, 1= POP until 2 cm before the hymnal line, 2= POP reached the hymnal line, 3= POP exceeds the hymnal line, 4= full extravgtnal prolapse)
- Defecation function [ Time Frame: 12 months ]Altomare score (6 items, minimum=0, maximum = 32 points; the more points, the worse the defecation function)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- suffering from obstructed defecation and pelvic organ prolapse
- can undergo general anesthesia
- is eligible for laparoscopic surgery
Exclusion Criteria:
- pregnancy
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05910021
Contact: Claudia Rudroff, PD Dr. | +492214795100 | claudia@rudroff.com | |
Contact: Sebastian Ludwig, PD Dr. | +494780 | sebastian.ludwig@uk-koeln.de |
Germany | |
EVK Koeln Weyertal | Recruiting |
Cologne, NRW, Germany, 50931 | |
Contact: Claudia Rudroff, PD Dr. +492114795100 claudia@rudroff.com | |
Contact: Claudia Rudroff, PD Dr. +4915123534935 claudia.rudroff@evk-koeln.de |
Principal Investigator: | Claudia Rudroff | EVK Köln Weyertal |
Responsible Party: | Claudia Rudroff, Chief of the Department of General and visceral Surgery, Evangelisches Klinikum Köln Weyertal gGmbH |
ClinicalTrials.gov Identifier: | NCT05910021 |
Other Study ID Numbers: |
EVK KOELN RRP_SCP_interdisciplinary ( Other Identifier: EVK Köln ) |
First Posted: | June 18, 2023 Key Record Dates |
Last Update Posted: | June 23, 2023 |
Last Verified: | June 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | Data available upon request to the study coordinator. |
Supporting Materials: |
Study Protocol Informed Consent Form (ICF) |
Time Frame: | 01.01.2024-31.12.2027 |
Access Criteria: | Access upon request to the study coordinator. |
URL: | https://evk-koeln.de |
Urinary Incontinence Constipation Prolapse Pelvic Organ Prolapse Urination Disorders Urologic Diseases Female Urogenital Diseases |
Female Urogenital Diseases and Pregnancy Complications Urogenital Diseases Male Urogenital Diseases Lower Urinary Tract Symptoms Urological Manifestations Signs and Symptoms, Digestive Pathological Conditions, Anatomical |